Five charts to start your day
Drugs now play a critical role in fighting the global obesity epidemic
Novo Nordisk's Wegovy and Ozempic, alongside Eli Lilly's Mounjaro, have shown exponential growth in sales over recent quarters. These drugs now play a critical role in the healthcare industry, especially as obesity rates continue to rise worldwide. Take a look at the chart below. Sales of obesity drugs Wegovy (Novo Nordisk), Ozempic (Novo Nordisk) and Mounjaro (Eli Lilly) have exploded.
Companies like Novo Nordisk and Eli Lilly are not only responding to immediate health needs of their patients, but are also shaping future market trends in pharmaceuticals for chronic conditions such as obesity.
This sustained increase in sales for both companies reinforces the importance these drugs play in treating conditions linked to numerous health complications and the increased economic burden caused worldwide.
Source: Yahoo Finance
Coming up:
Novo’s weight loss drugs are booming
Share of Europeans working from home
The UK's youth are facing uphill battles for jobs and homes
The Toronto Stock Exchange dividend yield relative to the the S&P 500
If you like the sound of that line up, this is usually a paid newsletter. You basically get all my best ideas daily. Hit the subscribe button if you are interested and this will be sent to your inbox daily.
